These agents are not intended to treat sepsis, though preclinical models suggest targeting host PCD machinery may be beneficial, as si-RNA inhibition of BIM, a pro-apoptotic protein, limits lymphocyte apoptosis and improves overall survival in septic mice, and similar results are achieved by repressing CASP8 (69–71). Here, BCL2L11 is linked to Sepsis.